GODAVARI exchange filings, corporate actions and results
3 Sep 2026
⚑ Filing
Godavari Drugs Ltd - 530317 - Intimation Of Dispatch Of Physical Letters Pursuant To Regulation 36(1)(B) Of The SEBI (LODR) RegulationsBSE filing · raw filing ↗
3 Sep 2026
⚑ Filing
Godavari Drugs Ltd - 530317 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
Godavari Drugs Ltd - 530317 - 39Th AGM To Be Held On 25Th Sep 2026 At 11.00 A.M. Through Video ConferencingBSE filing · raw filing ↗
1 Sep 2026
⚑ Filing
Godavari Drugs Ltd - 530317 - 38Th AGM To Be Held On 25.09.2026 - Book Closure - 19.09.2026 - 25.09.2026 (Both Days) And Evoting, Cutoff Date.BSE filing · raw filing ↗
1 Sep 2026
⚑ Filing
Godavari Drugs Ltd - 530317 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationBSE filing · raw filing ↗
31 Aug 2026
⚑ Filing
Godavari Drugs Ltd - 530317 - Board Meeting Outcome for Outcome Of Board Meeting Held On 31.08.2026 - Alteration Of The Main Objects Clause III(A) Of The Memorandum Of Association And Approval Of Revised Notice Of The 38Th Annual General MeetingBSE filing · raw filing ↗
17 Aug 2026
⚑ Filing
Godavari Drugs Ltd - 530317 - Submission Of Statement On Deviation Or Variation In Utilisation Of Funds For The Quarter Ended 30 June 2026BSE filing · raw filing ↗
17 Aug 2026
⚑ Filing
Godavari Drugs Ltd - 530317 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
14 Aug 2026
⚑ Filing
Godavari Drugs Ltd - 530317 - Announcement under Regulation 30 (LODR)-AllotmentBSE filing · raw filing ↗
14 Aug 2026
⚑ Result
Q1 FY27 results filed — revenue ₹28 Cr (+17.4% YoY), PAT ₹1 Cr (+6.6% YoY)BSE filing · raw filing ↗
14 Aug 2026
⚑ Filing
Godavari Drugs Ltd - 530317 - Board Meeting Outcome for Outcome Of Board Meeting Held On 14.08.2026BSE filing · raw filing ↗
11 Aug 2026
⚑ Filing
Godavari Drugs Ltd - 530317 - Update on board meetingBSE filing · raw filing ↗
10 Aug 2026
⚑ Result
Godavari Drugs Ltd - 530317 - Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results Of The Company For The Quarter Ended June 30, 2026.BSE filing · raw filing ↗
23 Mar 2026
⚑ Filing
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
23 Mar 2026
⚑ Filing
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
20 Mar 2026
⚑ Filing
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
20 Mar 2026
⚑ Filing
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
20 Mar 2026
⚑ Filing
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
20 Mar 2026
⚑ Filing
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
20 Mar 2026
⚑ Filing
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
20 Mar 2026
⚑ Filing
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
20 Mar 2026
⚑ Filing
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
20 Mar 2026
⚑ Filing
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
20 Mar 2026
⚑ Filing
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
